AMEX:CHAC

Stock Analysis Report

Executive Summary

Chardan Healthcare Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America.


Snowflake Analysis

Overvalued with worrying balance sheet.

Share Price & News

How has Chardan Healthcare Acquisition's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CHAC has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

3.0%

CHAC

0.4%

US Capital Markets

0.06%

US Market


1 Year Return

n/a

CHAC

17.9%

US Capital Markets

19.3%

US Market

Return vs Industry: Insufficient data to determine how CHAC performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how CHAC performed against the US Market.


Shareholder returns

CHACIndustryMarket
7 Day3.0%0.4%0.06%
30 Day4.2%0.7%1.7%
90 Day0.5%6.9%9.0%
1 Yearn/a20.2%17.9%21.8%19.3%
3 Yearn/a40.2%32.4%49.5%39.9%
5 Yearn/a84.5%67.4%73.1%54.1%

Price Volatility Vs. Market

How volatile is Chardan Healthcare Acquisition's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Chardan Healthcare Acquisition undervalued compared to its fair value and its price relative to the market?

4.85x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: CHAC ($10.55) is trading above our estimate of fair value ($0.34)

Significantly Below Fair Value: CHAC is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CHAC is unprofitable, so we can't compare its PE Ratio to the Capital Markets industry average.

PE vs Market: CHAC is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CHAC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CHAC is good value based on its PB Ratio (4.8x) compared to the US Capital Markets industry average (6.6x).


Next Steps

Future Growth

How is Chardan Healthcare Acquisition forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

48.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CHAC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CHAC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CHAC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if CHAC's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if CHAC's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CHAC's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Chardan Healthcare Acquisition performed over the past 5 years?

-4553.9%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: CHAC is currently unprofitable.

Growing Profit Margin: CHAC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if CHAC's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare CHAC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CHAC is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (20.6%).


Return on Equity

High ROE: CHAC has a negative Return on Equity (1.12%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Chardan Healthcare Acquisition's financial position? (This company is analysed differently as a bank or financial institution)


Financial Position Analysis


Debt to Equity History and Analysis


Balance Sheet

Inventory Level: CHAC has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if CHAC's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CHAC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CHAC has less than a year of cash runway if free cash flow continues to reduce at historical rates of -168.7% each year


Financial Institutions Analysis

Asset Level: CHAC's level of assets compared to its equity is moderate.

Allowance for Bad Loans: Insufficient data to determine if CHAC has a sufficient allowance for bad loans.

Low Risk Liabilities: CHAC reports no customer deposits, loans are made up entirely of externally borrowed funds.

Loan Level: Insufficient data to determine if CHAC has an acceptable proportion of non-loan assets held.

Low Risk Deposits: CHAC has advanced significantly more loans than the customer deposits it holds.

Level of Bad Loans: Insufficient data to determine if CHAC has an appropriate level of bad loans.


Next Steps

Dividend

What is Chardan Healthcare Acquisition's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.9%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate CHAC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CHAC's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CHAC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CHAC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CHAC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.8yrs

Average board tenure


CEO

Jonas Sven Grossman (45yo)

1.9yrs

Tenure

0

Mr. Jonas Sven Magnus Grossman serves as President and Director of Chardan Healthcare Acquisition Corp. and has been its Chief Executive Officer since November 2017. Mr. Grossman is the President of Charda ...


Board Members

NamePositionTenureCompensationOwnership
Gbolahan Amusa
Executive Chairman of the Board1.6yrsno datano data
Jonas Sven Grossman
President1.9yrsno datano data
George Kaufman
CFO, Head of Strategy & Director0yrsno datano data
Richard Giroux
Independent Director0.8yrsno data0.33% $79.1k
Michael Rice
Independent Director0.8yrsno data0.33% $79.1k
Eric Kusseluk
Independent Director0.8yrsno data0.33% $79.1k
Matthew Rossen
Independent Director0.8yrsno data0.33% $79.1k

0.8yrs

Average Tenure

45yo

Average Age

Experienced Board: CHAC's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.1%.


Top Shareholders

Company Information

Chardan Healthcare Acquisition Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Chardan Healthcare Acquisition Corp.
  • Ticker: CHAC
  • Exchange: AMEX
  • Founded: 2017
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Market Cap: US$24.225m
  • Shares outstanding: 2.30m
  • Website: https://chardan.com/

Location

  • Chardan Healthcare Acquisition Corp.
  • 17 State Street
  • 21st Floor
  • New York
  • New York
  • 10004
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CHAC.UAMEX (NYSE MKT LLC)UnitsUSUSDDec 2018
CHACAMEX (NYSE MKT LLC)YesCommon StockUSUSDMar 2019

Biography

Chardan Healthcare Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was founded in 2017 and is based in New York, New York. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/29 01:05
End of Day Share Price2019/10/28 00:00
Earnings2019/09/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.